|
Objective: A number of granules Chaxiang HAART therapy when combined with the onset of AIDS patients on clinical symptoms total score , CD4 T cells and viral load impact . Methods: This study is based Hunan many AIDS Clinical experience of experts , selected A1, Hunan , Hunan A2, granules, multi-center , randomized, controlled , double-blind test method , with its combination with antiviral drugs , together at the onset of AIDS patients . Results : After treatment, total symptom score among the three groups , A group and B group , P = 0.766, P> 0.05, A group and B group showed no statistical significance between ; A group, C group and B group , comparison between group C , P <0.05, can be considered as a , B group therapy onset of AIDS patients when its effect is to improve the patient 's signs and symptoms than the control group C group . After treatment, CD4 T-cell counts among the three groups , A , B group (P = 0.032) in group A , C group (P = 0.04) compared to , P <0.05, A group and B group comparison between , A group between the C group , the difference was statistically significant : B comparison between group C , P = 0.452, P gt; 0.05, can be considered as group B and C group , the difference was not statistically significant. After treatment, the viral load among the three groups , A group and B group , P = 0.959, P gt; 0.05, A group and B group showed no statistical significance between ; A group, C group (P = 0.002) and B group, C group (P = 0.003) between the comparison , P <0.05, can be considered as a , B group therapy onset of AIDS patients , it reduces the effect of viral load than the control group C group . Before and after treatment in each group safety index comparison among groups P values ??were greater than 0.05, the difference was not statistically significant , can be seen between the groups safety indicators showed no significant difference , which we can think of granules used Gordon A incidence of AIDS patients is relatively safe. Conclusion: It follows , Gordon A, granules in improving clinical symptoms and signs , regulating immunity in patients and reduce side effects of antiviral therapy to bring the auxiliary reducing viral load , and so has a certain role.
|